Avicienna Insitute

We are a consortium funded by the European Commission, tasked with three objectives:

01

ROADMAP

Creating a roadmap addressing the steps needed for the introduction of in silico clinical trials.
02

BIOMEDICAL INDUSTRY PARTNERSHIP

Establishing a partnership between the biomedical industry and European research organisations, with the aim of developing the technology, methods, protocols and standards required for in silico clinical trials to become a reality.
03

TECHNOLOGIES

. Identifying technologies, determining early examples of in silico clinical trails.

WHAT IS Avicenna

Avicenna – A Strategy for in silico Clinical Trials is a Coordination and Support Action funded by the European Commission as part of the Seventh Framework Program for Research and Technological Development (FP7), under the Information Communication Technologies Programme (Contract Number 611819).

UE

Research and Technological Development

Avicenna – A Strategy for in silico Clinical Trials is a Coordination and Support Action funded by the European Commission as part of the Seventh Framework Program for Research and Technological Development (FP7), under the Information Communication Technologies Programme (Contract Number 611819).

Avicenna Consortium

Avicenna Consortium

LATEST NEWS & BLOGS